BRD2 and benign prostatic hyperplasia: In NP-D, Timp1 and Timp2 are approximately nine- and 14-fold higher in NAT BPH/5 females compared to NAT C57 (Figure 4A,D; p = 0.035 and p = 0.015, respectively).